tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ANAB Stock Latest News

Anaptys Announces Participation in September Investor Conferences
Press ReleasesAnaptys Announces Participation in September Investor Conferences
17d ago
ANAB
AnaptysBio management to meet virtually with BTIG
PremiumThe Fly
AnaptysBio management to meet virtually with BTIG
24d ago
ANAB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
29d ago
OGI
ANAB
AnaptysBio price target raised to $30 from $20 at Truist
PremiumThe Fly
AnaptysBio price target raised to $30 from $20 at Truist
1M ago
ANAB
AnaptysBio to sell 2.75M shares at $36.50 in registered direct offering
PremiumThe Fly
AnaptysBio to sell 2.75M shares at $36.50 in registered direct offering
1M ago
ANAB
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
PremiumPress ReleasesAnaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
1M ago
ANAB
AnaptysBio price target raised to $42 from $34 at Wedbush
Premium
The Fly
AnaptysBio price target raised to $42 from $34 at Wedbush
1M ago
ANAB
AnaptysBio reiterates cash runway through year-end 2026
Premium
The Fly
AnaptysBio reiterates cash runway through year-end 2026
1M ago
ANAB
AnaptysBio reports Q2 EPS ($1.71), consensus (89c)
PremiumThe Fly
AnaptysBio reports Q2 EPS ($1.71), consensus (89c)
1M ago
ANAB
Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
1M ago
ANAB
ANAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ANAB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
ANAB
AnaptysBio initiated with a Buy at H.C. Wainwright
PremiumThe Fly
AnaptysBio initiated with a Buy at H.C. Wainwright
2M ago
ANAB
Arm and Accenture upgraded: Wall Street’s top analyst calls
PremiumThe FlyArm and Accenture upgraded: Wall Street’s top analyst calls
2M ago
ED
WH
AnaptysBio upgraded to Overweight from Neutral at JPMorgan
Premium
The Fly
AnaptysBio upgraded to Overweight from Neutral at JPMorgan
2M ago
ANAB
Anaptys participates in a conference call with JPMorgan
Premium
The Fly
Anaptys participates in a conference call with JPMorgan
2M ago
ANAB
AnaptysBio price target raised to $29 from $28 at JPMorgan
PremiumThe Fly
AnaptysBio price target raised to $29 from $28 at JPMorgan
4M ago
ANAB
AnaptysBio announces GEMINI-2 Phase 3 trial results
PremiumThe Fly
AnaptysBio announces GEMINI-2 Phase 3 trial results
4M ago
ANAB
AnaptysBio to receive $50M from amended agreement with Sagard
PremiumThe Fly
AnaptysBio to receive $50M from amended agreement with Sagard
4M ago
ANAB
AnaptysBio reports Q1 EPS ($1.64), consensus ($1.57)
PremiumThe Fly
AnaptysBio reports Q1 EPS ($1.64), consensus ($1.57)
4M ago
ANAB
Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
PremiumPress ReleasesAnaptys Announces First Quarter 2024 Financial Results and Provides Business Update
4M ago
ANAB
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
Premium
Press Releases
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
4M ago
ANAB
AnaptysBio management to meet with Piper Sandler
Premium
The Fly
AnaptysBio management to meet with Piper Sandler
5M ago
ANAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >